معرفی
Dr. Danqing Min is a Senior Research Fellow at the Central Clinical School, University of Sydney, and a member of the Charles Perkins Centre. Her research focuses on understanding molecular mechanisms of inflammation in diabetic complications, particularly investigating monocyte/macrophage roles, matrix metalloproteinases (MMPs), and therapeutic interventions. She has published extensively on biomarkers for diabetic complications, wound healing in diabetes, and exercise interventions. Her work spans cellular/molecular approaches and animal models, with a focus on obesity, diabetes, and cardiovascular disease. Current research includes CD163 regulation in diabetes complications and the role of monocyte phenotypes in wound healing.
Research Themes: Obesity, Diabetes and Cardiovascular Disease; Infection and Immunological Conditions; Healthy Ageing.
Recent Research: Dr. Min’s recent work emphasizes biomarker discovery (e.g., soluble CD163, MMP-9), exercise’s impact on metabolic disorders, and monocyte dysfunction in diabetes. Her articles highlight translational research linking molecular mechanisms to clinical outcomes, such as diabetic foot ulcers and nephropathy.
Grants & Funding: Key grants include studies on exercise training for diabetic foot ulcers (2022, ESSA Grant), exercise for non-alcoholic steatohepatitis (2020, Diabetes Australia), and monocyte-CD163 mechanisms (2017, Diabetes Australia).
Labs/Teams: Active member of the Charles Perkins Centre, collaborating with experts in diabetes, immunology, and metabolic research.
